-transparent.png){kind=logo}
Occupational asthma after exposure to salbutamol in the pharmaceutical industry has not been previously reported. The occurrence of occupational asthma is described in two pharmaceutical process workers who were likely to have inhaled doses appreciably in excess of the therapeutic dose range. The findings do not lead to an unequivocal conclusion on the mechanism of the asthma but it was probably a pharmacological consequence of high exposure.
Related Publications
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
August 2022,
Occupational medicine (Oxford, England),
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
February 1984,
The Journal of allergy and clinical immunology,
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
March 2004,
Current opinion in pulmonary medicine,
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
January 2009,
Thorax,
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
May 1997,
Allergy,
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
January 1966,
Le Poumon et le coeur,
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
October 2022,
Occupational medicine (Oxford, England),
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
September 1984,
The Journal of allergy and clinical immunology,
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
March 2002,
Medicina clinica,
R M Agius, and
A G Davison, and
E R Hawkins, and
A J Newman Taylor
December 1973,
Gigiena truda i professional'nye zabolevaniia,
